Novel therapeutic target for multiple sclerosis

Summaries of newsworthy papers: Disease: Novel therapeutic target for multiple sclerosis; Neuroscience: Coloured judgement

This press release contains:

• Summaries of newsworthy papers:

Disease: Novel therapeutic target for multiple sclerosis
Neuroscience: Coloured judgement

• Geographical listing of authors

Warning: This document, and the Scientific Reports paper to which it refers, may contain information that is price sensitive (as legally defined, for example, in the UK Criminal Justice Act 1993 Part V) with respect to publicly quoted companies. Anyone dealing in securities using information contained in this document or in advanced copies of Scientific Reports’ content may be guilty of insider trading under the US Securities Exchange Act of 1934.

A PDF of the papers mentioned on this release can be found in the Scientific Reports section of http://press.nature.com. Press contacts are listed at the end of this release.

PICTURES: While we are happy for images from Scientific Reports to be reproduced for the purposes of contemporaneous news reporting, you must also seek permission from the copyright holder (if named) or author of the research paper in question (if not).

HYPE: We take great care not to hype the papers mentioned on our press releases, but are sometimes accused of doing so. If you ever consider that a story has been hyped, please do not hesitate to contact us at [email protected], citing the specific example.

PLEASE CITE SCientific Reports AND THE scientific reports WEBSITE AS THE SOURCE OF THE FOLLOWING ITEM. IF PUBLISHING ONLINE, PLEASE CARRY A HYPERLINK TO www.nature.com/scientificreports

[1] Disease: Novel therapeutic target for multiple sclerosis
DOI: 10.1038/srep00079

A metabolic pathway that could represent a new therapeutic strategy for multiple sclerosis (MS) is revealed in a mouse study in Scientific Reports this week.

MS is an inflammatory demyelinating disease of the central nervous system (CNS) and affects millions of individuals worldwide. But the disease’s complex immunopathology means it has proved difficult to identify effective therapeutic targets. Previous research has indicated that fatty acid oxidation may be important for the activity and survival of inflammatory cells, especially under conditions of limited metabolic fuel. Leah Shriver and Marianne Manchester studied the effect of inhibiting fatty acid metabolism in experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. They found that treatment with a small-molecule inhibitor of fatty acid metabolism reduced EAE symptoms and inflammation in mice.

The results suggest that fatty acid metabolism plays a role in MS by sustaining the inflammatory response within the CNS. This metabolic pathway could therefore be a potential therapeutic target for MS.

CONTACT

Marianne Manchester (University of California, San Diego, La Jolla, CA, USA)
Tel: +1 858 534 6624; E-mail: [email protected]

Please link to the freely available scientific paper in online versions of your report (the URL will go live after the embargo ends):
www.nature.com/srep/2011/110901/srep00079/full/srep00079

[2] Neuroscience: Coloured judgement
DOI: 10.1038/srep00080

When detecting potentially dangerous stimuli, such as snakes, human children, unlike adults, appear to attend selectively to their colour rather than their shape, leading to faster decisions but at the expense of precision. The findings are published online in Scientific Reports this week.

Humans are extremely sensitive to biologically threatening stimuli, such as snakes, and it has been suggested that certain basic properties of the human visual system might have evolved precisely because they facilitated the detection of such fear-relevant stimuli. Nobuo Masataka and colleagues investigated the role of colour in the detection of fear-relevant stimuli in human children. The authors showed 111 children, aged between four and six years old, matrices containing either one snake image and eight flower images, or vice-versa. The images were presented either in colour or in grey-scale and participants had to detect the target image as quickly as possible.

As in previous studies on adult humans, all participants detected target snakes faster than target flowers. However, children also responded both to target snakes and target flowers faster when the images were presented in colour than in grey-scale. Conversely, although adults in the previous studies detected target flowers more quickly in colour than in gray-scale, they responded to snake targets equally quickly whether the images were in colour or in grey-scale.

When detecting snakes, human children therefore appear to focus mainly on their colour, which contributes towards a faster but less precise response. Adults, on the other hand, use the distinctive shape of snakes to help identify them as a target, regardless of colour.

CONTACT

Nobuo Masataka (Kyoto University, Inuyama, Japan)
Tel: +81 568 630 552; E-mail: [email protected]

Please link to the freely available scientific paper in online versions of your report (the URL will go live after the embargo ends):
www.nature.com/srep/2011/110901/srep00080/full/srep00080

GEOGRAPHICAL LISTING OF AUTHORS…

The following list of places refers to the whereabouts of authors on the papers numbered in this release. For example, London: 4 - this means that on paper number four, there will be at least one author affiliated to an institute or company in London. The listing may be for an author's main affiliation, or for a place where they are working temporarily. Please see the PDF of the paper for full details.

JAPAN
Inuyama: 2
Nagoya: 2

UNITED STATES OF AMERICA
California
La Jolla: 1

PRESS CONTACTS…

From North America and Canada
Neda Afsarmanesh, Nature, New York
Tel: +1 212 726 9231; E-mail: [email protected]

From Japan, Korea, China, Singapore and Taiwan
Mika Nakano, Nature, Tokyo
Tel: +81 3 3267 8751; E-mail: [email protected]

From the UK
Rebecca Walton, Nature, London
Tel: +44 20 7843 4502; E-mail: [email protected]

About Nature Publishing Group (NPG):
Nature Publishing Group (NPG) is a publisher of high impact scientific and medical information in print and online. NPG publishes journals, online databases and services across the life, physical, chemical and applied sciences and clinical medicine.

Focusing on the needs of scientists, Nature (founded in 1869) is the leading weekly, international scientific journal. In addition, for this audience, NPG publishes a range of Nature research journals and Nature Reviews journals, plus a range of prestigious academic journals including society-owned publications. Online, nature.com provides over 5 million visitors per month with access to NPG publications and online databases and services, including Nature News and NatureJobs plus access to Nature Network and Nature Education’s Scitable.com.

Scientific American is at the heart of NPG’s newly-formed consumer media division, meeting the needs of the general public. Founded in 1845, Scientific American is the oldest continuously published magazine in the US and the leading authoritative publication for science in the general media. Together with scientificamerican.com and 15 local language editions around the world it reaches over 3 million consumers and scientists. Other titles include Scientific American Mind and Spektrum der Wissenschaft in Germany.

Throughout all its businesses NPG is dedicated to serving the scientific and medical communities and the wider scientifically interested general public. Part of Macmillan Publishers Limited, NPG is a global company with principal offices in London, New York and Tokyo, and offices in cities worldwide including Boston, Buenos Aires, Delhi, Hong Kong, Madrid, Barcelona, Munich, Heidelberg, Basingstoke, Melbourne, Paris, San Francisco, Seoul and Washington DC. For more information, please go to www.nature.com.

Published: 01 Sep 2011

Contact details:

The Macmillan Building, 4 Crinan Street
London
N1 9XW
United Kingdom

+44 20 7833 4000
Country: 
News topics: 
Content type: 
Websites: